PEDIATRICS Vol. 59 No. 2 February 1977, pp. 212-218
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, J. C.

Methotrexate and Azathioprine Treatment of Childhood Dermatomyositis

Jerry C. Jacobs M.D.1

1 Department of Pediatrics, Columbia University College of Physicians and Surgeons, Babies Hospital, Children's Medical and Surgical Center, and the Edward Daniels Faulkner Arthritis Clinic, Columbia-Presbyterian Medical Center, New York, New York

Modern treatment of childhood dermatomyositis with corticosteroids has resulted in greatly improved prognosis and style of life. The immunosuppressive drugs methotrexate and azathioprine have been utilized as ancillary agents in life-threatening disease and in children whose disease could not be adequately controlled with prednisone alone. Two patients are completely well without medication two and seven years after onset; two have received no medications for more than two years and have only subtle signs of any residual illness although they had been profoundly ill for two to three years after the onset of dermatomyositis. A fifth patient, completing the third year of disease, remains ill and continues to require medications but has improved sufficiently to return to regular class in school.

Submitted on March 12, 1976
Accepted on June 21, 1976




This article has been cited by other articles:


Home page
 J Child NeurolHome page
Y.-t. Ng, R. A. Ouvrier, and T. Wu
Drug Therapy in Juvenile Dermatomyositis: Follow-Up Study
J Child Neurol, March 1, 1998; 13(3): 109 - 112.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
H. M. Schroter, H. B. Sarnat, D. S. Matheson, and T. P. Seland
Juvenile Dermatomyositis Induced by Toxoplasmosis
J Child Neurol, April 1, 1987; 2(2): 101 - 104.
[Abstract] [PDF]